上证早知道｜央行，今日操作；事关创新药，国家医保局宣布；上期所，调整手续费

Monetary Policy and Market Operations - The People's Bank of China will conduct a 700 billion yuan reverse repurchase operation on November 5, 2025, to maintain liquidity in the banking system, with a term of 3 months [1][2] - In October 2025, the central bank's liquidity injection included a net investment of 200 billion yuan in government bonds, 4 billion yuan in reverse repos, and 2 billion yuan in medium-term lending facilities [2] Stock Market and New Accounts - In October 2025, A-share new accounts totaled 2.3099 million, a decrease of 21.36% from September and a 66.26% drop year-on-year [2] Commodity Futures and Trading Fees - Starting November 10, 2025, trading fees for aluminum alloy futures and printing paper futures will be adjusted to 0.0005 of the transaction amount, with no fees for intraday closing positions [3] Automotive Industry - In October 2025, wholesale sales of new energy passenger vehicles reached 1.61 million units, a year-on-year increase of 16% and a month-on-month increase of 7% [2] Healthcare and Pharmaceuticals - The negotiation for the 2025 National Basic Medical Insurance Drug List has concluded, with a new drug list set to be released in December 2025 and implemented on January 1, 2026 [5] - The global innovative drug market is projected to grow from $1.1 trillion in 2024 to $1.5 trillion by 2030, with significant market opportunities for Chinese innovative drugs [5] Technology and Electronics - Nintendo has raised its sales forecast for the Switch 2 to 19 million units by March 2026, reflecting strong market demand [6] - The consumer electronics industry is expected to grow, driven by AI technology and stable demand in various regions [6] Investment and Financing - In the fourth quarter of 2025, equity ETFs have attracted over 100 billion yuan in net subscriptions, indicating strong investor interest [10]